LORD, ABBETT & CO. LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 54 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2015$5,194,000
-49.4%
4,005,000
-39.6%
0.02%
-40.7%
Q2 2015$10,256,000
+17.9%
6,633,000
+13.8%
0.03%
+22.7%
Q1 2015$8,702,000
+1251.2%
5,828,000
+863.3%
0.02%
+1000.0%
Q3 2014$644,000
-85.1%
605,000
-85.5%
0.00%
-60.0%
Q2 2014$4,324,000
-34.0%
4,160,000
-30.2%
0.01%
-66.7%
Q1 2014$6,556,000
-38.9%
5,957,000
-40.9%
0.02%
-37.5%
Q4 2013$10,724,00010,075,0000.02%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2015
NameSharesValueWeighting ↓
Ferox Capital Management LP 6,000,000$6,271,0004.60%
Weiss Asset Management LP 27,058,000$28,040,0002.16%
Birch Grove Capital LP 4,643,000$4,802,0001.91%
CSS LLC/IL 20,256,000$20,993,0000.89%
PIPER SANDLER & CO. 1,000,000$1,036,0000.86%
AQR Arbitrage LLC 24,825,000$25,686,0000.30%
CAPSTONE INVESTMENT ADVISORS, LLC 17,000,000$17,589,0000.20%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 5,000,000$5,182,000,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 4,107,000$4,256,0000.12%
Verition Fund Management LLC 3,106,000$3,214,0000.12%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders